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Abstract
Bromelain is an extract obtained from the pineapple plant
and is used as a traditional folk remedy for several
ailments. In this review, a comprehensive electronic
database search was carried out to compile available
literature on therapeutic implications of bromelain.
Pharmaceutical value of bromelain has been demonstrated
in different surgical sub-specialties. Diverse biological
processes like anti-inflammatory, anti-oedematous,
analgesic, anti-thrombotic, exfoliation etc. are involved in
bromelain's therapeutic actions, mediated through the
kallikrein-kinin and arachidonic acid pathways as well as
through effects on cell mediated immunity.
Bromelain equals non-steroidal anti-inflammatory drugs
as an anti-inflammatory agent, but has been shown to
have fewer side effects. In Europe it is approved for oral
and topical use, mainly for surgical wounds, inflammation
due to trauma and surgery, and debridement of deep
burns. Literature suggests a promising role of bromelain
in surgical care. More clinical trials to establish its utility as
an anti-inflammatory agent in surgical care are
recommended.
Keywords: Bromelain, Pineapple, Wound healing,
Inflammation, Anti-inflammatory, debridement.
Introduction
Bromelain is a crude extract derived from pineapple plant
(Ananas comosus) and contains mixture of proteolytic
enzymes and non-enzymatic substances. It is used as a folk
remedy bymany native cultures like Philippines, Hawaii etc.
Several research studies have shown beneficial effects of
bromelain in diverse health-related conditions. Bromelain's
relevance is evident from reports of its beneficial effects in
resolving swelling, inflammation, bruising and pain
associated with trauma and surgery. Bromelain is not only
effective but also has fewer adverse effects as compared to
non-steroidal anti-inflammatory drugs (NSAIDs).1-6
In this review, we present the current available scientific
literature covering mechanism of action and therapeutic
role of bromelain in surgical care and related conditions.
Bibliographic search with emphasis on key words
'bromelain, surgery, inflammation, wound' and phrases
'bromelain in surgical care and surgical wound, anti-
inflammatory effect of bromelain etc. was carried out
from available data using PubMed database filter (year
1957-2016), Google Scholar, Ovid and specific journals
were also searched individually. Total 2,880 articles were
searched in which 1,550 were with anti-inflammatory
effect of bromelain in surgical care. Out of these articles,
only most pertinent research articles with oral
administered bromelain (separately or in proteolytic
enzyme complex) or topical application of bromelain in
different surgical care practices were selected. Those
articles with intravenous route of bromelain
administration as well as those involving bromelain
effects on cancer and combination therapies were
excluded. Our aim was to review and explore current
evidence based primary data with respect to application
of bromelain therapy in surgical practice.
Sources
Bromelain has two main sources: Fruit bromelain (EC
3.4.22.33) extracted from pineapple fruit and Stem
bromelain (EC 3.4.22.32) extracted from inedible pineapple
stem.7 Stembromelain is economical to produce; hence it is
the more commonly available commercial product. It is
composed of endopeptidases (ananain, comosain),
phosphatases, glucosidases, peroxidases, escharase,
cellulases, glycoproteins, proteinase inhibitors (cystatin),
calcium and carbohydrate.8-11 The proteolytic activity of
bromelain is sensitive to storage conditions and
biochemical processing thus, it is not practical to take
therapeutic amount of bromelain by oral consumption of
raw pineapple fruit as a substitute for bromelain
supplements.12
Mechanism of action
Several in vivo and in vitro studies have been conducted
on the anti-inflammatory activity of bromelain but the
actual mechanism of anti-inflammatory effect is not fully
established.
(a) Kallikrein-kinin pathway
Studies show that bromelain's anti-inflammatory and
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analgesic activity is due to lowering plasmakinin
(bradykinin) at inflammatory site and lowering
prostaglandin E2 levels. In vitro experiments showed that
bromelain activates plasma prekallikrein by activation of
factor XII.13 In rat experiments, it is shown that bromelain-
derived plasminogen activator leads to production of
plasmin. The plasmin cleaves Hageman factor in a way that
results in a strong release of kallikrein but a weak release of
thrombin. Intravenous bromelain administration in rats
markedly reduced plasma prekallikrein and high
molecular weight kininogen 15minutes after the injection,
and the effect lasted for 72 hours.14
Bromelain has been demonstrated to inhibit thrombus
formation when administered orally and intravenously.15,16
The effect may be related to reduction in levels of high
molecular weight kininogen and weak release of thrombin.
(b) Arachidonic acid pathway
It is also demonstrated that bromelain increases platelet
cyclic adenosine monophosphate (cAMP) levels thus
increasing prostaglandin (PG) I2 and PGE1 levels. A
possible mechanism is suggested that the dominant
endogenous prostaglandins being produced must be
from the group that increases platelet cAMP levels
(prostacyclin, PGE1, etc.). In in-vivo experimentally-
induced inflammatory reaction in rats, bromelain was
tested for its action on eicosanoids production. It was
identified that arachidonic acid cascade was affected by
bromelain.17 Bromelain, when administered orally in
doses of 10 and 20 mg/kg, significantly decreased PGE2
and substance P concentrations in the exudate in rats
with subcutaneous carrageenan-induced inflammation.
In in-vitro experiment, PGE 2 levels were not affected by
bromelain although substance P level was increased.18
(c) Cell Mediated Immunity
In in-vitro and in-vivo studies, it was observed that
bromelain has anti-inflammatory effect by modulating
leukocyte cell surface molecules like CD 14, CD 44, CD 16,
CD 21, CD 128 a and b which are involved in leukocyte
homing, cellular adhesion, induction of pro-inflammatory
mediators and immunomodulatory effect on T cells by
inhibition of T cell signal transduction, producing effect on
Th1, Th2 and immunosuppressive cytokines, etc. Bromelai
also reduce P-selectinmediated neutrophil recruitment.19-21
Therapeutic uses of bromelain in trauma
and surgical care
Several clinical studies have demonstrated beneficial
effects of bromelain (Table) in a variety of conditions
related to surgical practice, as described below:
Perioperative
1. Orthopaedics: In a clinical trial, patients with long
bone fractures were treated with oral bromelain as a
proteolytic enzyme combination containing 90 mg
bromelain per tablet after surgery. Significant reduction in
pain and swelling with accelerated healing was observed
as compared to group of patients who were treated with
standard anti-inflammatory analgesics.22
2. Obstetrics: Bromelain, administered orally, has been
shown to be effective in reducing pain, ecchymosis and
edema due to episiotomy in a placebo-controlled, double
blind study.23 Another study showed a trend of similar
reduction but the difference did not achieve statistical
significance.24
3. Otolaryngology: In a randomized, placebo-controlled
study, it has been reported that oral bromelain minimizes
ecchymosis and edema after rhinoplasty.25
4. Dentistry: In patients who had undergone surgery for
impacted third molar, a randomized controlled study
showed that treatment with oral bromelain reduces post-
operative erythema, pain and inflammation.26 Other
randomized, double-blind, placebo-controlled clinical trial
showed significant reduction in pain by bromelain
Table: Reported therapeutic benefits of bromelain.
Setting Condition/patients Outcome References
Trauma Blunt soft tissue injury Reduced swelling and pain, early return to function 30
Artificially induced hematoma Rapid hematoma resorption 31,32,33
Orthopaedics Long bone fractures Reduced fracture pain and swelling, accelerated fracture healing 21
Sports medicine Ligament sprains Reduced pain, swelling and ecchymosis, earlier return to function 34,35,36,37,38
Obstetrics Episiotomy Reduced episiotomy pain, ecchymosis and edema 22,23,24
Otolaryngology Post-rhinoplasty Reduced ecchymosis and edema 25
Dentistry Post-extraction of impacted teeth Reduced erythema, pain and inflammation 26,27,28
Ophthalmology Cataract surgery Reduced inflammation and pain 29
Plastic surgery Open wounds and burns Effective debridement permitting early skin grafting 39,40,41,42,43,44
Haematology Cardiovascular and cerebrovascular disease Reduced platelet aggregation 14,45,46,47
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compared to placebo anddiclofenac, while yet another trial
showed non-significant reduction in inflammation.27,28
5. Ophthalmology: In a double-blind, placebo-controlled
clinical trial on patients undergoing cataract surgery, it was
demonstrated that oral bromelain administered two days
prior to surgery and five days post-operatively resulted in
significant reduction in inflammation and pain as
compared to the placebo group.29
Blunt trauma
In a series of patients suffering from blunt trauma injuries
to the musculoskeletal system, treatment with bromelain
resulted in subjective improvement in swelling, pain, and
tenderness at the site of injury with good tolerability,
although there was no control group.30
In a placebo controlled clinical trial, when subjects with
artificially induced haematomawere treatedwith bromelain,
there was a more rapid resorption of the haematoma and a
significantly lower volume of haematoma as compared to
placebo group.31 The mechanism of resolution was not
reported but in separate animal studies, inhibition of
bradykinin generation at injury site and increase in serum
fibrinolytic activity were observed, suggesting the probable
mechanism of haematoma resolution.32,33
Sports injuries
Literature shows mixed results for bromelain use in
treatment of sprains and strains. According to some
research studies it appears to reduce swelling, bruising,
redness and tenderness, and promotes rapid recovery
and healing. A double-blind placebo-controlled study
was conducted on patients having sports related ankle
injuries. Patients treated with oral bromelain had faster
recovery as compared to placebo group.34 In three small
double-blind studies, oral bromelain significantly healed
bruises and improved mild athletic injuries as compared
to placebo group.35-37
Contrary to this, in one big double-blind, placebo-controlled
randomized trials, patients with acute unilateral sprain of the
lateral ankle joint were treated either separately or in
combination with oral bromelain, trypsin or a bioflavonoid
rutin. Results showed significant difference in pain, swelling
and rangeofmotionas compared toplacebo treatedgroup.38
Skin wounds
Topical application of bromelain to skin wounds and burns
has been shown to be a safe and effective method for
debridement of necrotic tissue and is an alternate to surgical
debridement.39,40 Local application of bromelain has been
shown to be rapid, effective, non-invasive, safe, easily
performed at the bedsidewithminimal or noblood loss and
negligibly interfere with natural wound healing processes.41
Debridement of necrotic tissue is due to a non-proteolytic
component Escharase having molecular weight of 45,000
Daltons and is present in bromelain extract which also
helps in healing. Houck described method of isolating
escharase from stem of pineapple plant. Escharase helps
in digestion, dissection and separation of non-viable,
devitalized tissue, especially eschar tissue between the
viable native and the non-viable denatured burn tissue.42
A multi-center, open-label, randomized, controlled clinical
trial was conducted on patients 4 to 55 years of age with
deep partial and full thickness burns. Patients were treated
with a bromelain-rich topical agent NexoBrid which was
applied for 4 hours or by standard of care.Therewas reduced
time from to complete debridement, need for surgery and
need for autografting in bromelain treatment group.43
Coagulation
It has been reported that oral administration of bromelain
significantly lowers adenosine phosphate induced
platelet aggregation. Antiplatelet activity was determined
ex vivo.44 In one study, effect of bromelain was assessed
on human plasma fibrin (ogen) and blood coagulation.
Bromelain showed dual action on blood coagulation: at
low concentration showed procoagulant effect and at
high concentration anticoagulant effect.45 These findings
are of concern for surgeons and care needs to be
exercised in patients with bleeding disorders while
prescribing bromelain.
Contrary to above mentioned findings, some authors
identified that bromelain does not significantly affect blood
clottingmechanism inhealthy volunteers. In one clinical trial,
healthy volunteers and breast cancer patients were treated
with oral bromelain. The activated partial thromboplastin
time increased from 38 to 46 seconds, leaving prothrombin
time and plasminogen unchanged.46 In another clinical trial,
patients with oedema and inflammation were treated with
40 mg oral bromelain 4 times daily for 1 week. There was no
significant effect on bleeding, coagulation and prothrombin
time suggesting that therapeutic amount of bromelain does
not affect blood clotting.47
Approvals
On the basis of available positive research evidence, the
German Commission E approved bromelain as an effective
remedy to treat inflammation after ear, nose, throat and
trauma surgeries.48 In the United States, bromelain is
"generally recognized as safe" (21CFR184.1024) by the U.S.
Food and Drug Administration (FDA), though no approved
therapeutic indications are available due to lack of
required body of research evidence.
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Side effects
Although bromelain is generally safe, there are rare
reports of nausea, vomiting, diarrhea, allergic reaction
and unusual menstrual bleeding.49,50 As safety data is
scarce, it is advisable that pregnant women, patients with
bleeding disorders, hypertension, liver disease and kidney
disease should avoid bromelain.51,52
Bromelain's role against platelet aggregation may
increase the risk of bleeding during and after surgery. It
should be administered in patients under doctor's
supervision with special precautions. It is recommended
that bromelain should not be combined with
anticoagulant drugs such as warfarin, clopidogrel etc. and
should not be administered in bleeding disorders.
Dosage
Therapeutic management with bromelain is based on
medical condition for which it is being taken.
Adults
 The German Commission E recommended dosing in
ENT surgeries and trauma to be 80 - 320 mg orally 2 - 3
times per day for 8 days. For certain conditions higher
doses are also prescribed.
 For debridement of deep thermal skin burns, bromelain
is applied topically once for 4 hours in the form of debrase
gel dressing. Treatment is provided in specialized burn
centers under strict observation. Bromelain gel should not
be applied to more than 15% of the patient's total body
surface area and to the broken skin.
Paediatric
Bromelain is not recommended in children as there is no
reliable safety data available. A Paediatric Investigation Plan
(EMEA-000142-PIP02-09-M03) has been agreed by European
Medicines Agency (Decision number P/0072/2014) and its
proposed date of completion is March 2019.48
Conclusion
Literature search of 59 years suggest a promising role of
bromelain in surgical care on account of its anti-
inflammatory effect. Pineapple extracted Bromelain may
be used as a therapeutic agent in surgical care.
In surgical practice, further exploration of bromelain's role
as a therapeutic anti-inflammatory agent remains to be
established through more number of randomized
controlled clinical trials.
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